Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says [W[R]C]
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Chapters
Description
https://www.cnn.com/2023/02/24/health/pfizer-rsv-vaccine-guillain-barre/index.html CNN — Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration...
show moreCNN
—
Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday.
Information
Author | UniquilbriuM |
Organization | Flor and Hakeem |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company